venBio Global Strategic Fund L.P. 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-08 3:54 pm Purchase | 2020-07-06 | 13D | Akero Therapeutics, Inc. AKRO | venBio Global Strategic Fund L.P. | 3,033,552 10.600% | 3,033,552 (New Position) | Filing |